BG
BBNX

Bellevue Group’s Beta Bionics BBNX Stock Holding History

Bellevue Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Hold
72,152
– – 0.02% 101
2026
Q1 		$723K Sell
72,152
-133
-0.2% -$1.97K 0.02% 101
2025
Q4 		$2.2M Buy
72,285
+8,002
+12% +$214K 0.04% 94
2025
Q3 		$1.28M Sell
64,283
-2,542
-4% -$44.7K 0.03% 103
2025
Q2 		$973K Hold
66,825
– – 0.02% 104
2025
Q1 		$818K Buy
+66,825
New +$1.25M 0.02% 111

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Bellevue Group's BBNX Position: Q2 2026 in Review

Bellevue Group held its Beta Bionics (BBNX) position steady in Q2 2026 at 72,152 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #101.

Bellevue Group first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.2M in Q4 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Bellevue Group held 72,152 shares of Beta Bionics worth $1.13M as of Q2 2026.
  • Bellevue Group left its Beta Bionics share count unchanged in Q2 2026.
  • Beta Bionics made up 0.02% of Bellevue Group's portfolio in Q2 2026, its #101 holding.
  • Bellevue Group first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Bellevue Group's Beta Bionics position peaked at $2.2M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.